Frequency of Atrioventricular Block in Patients with Acute ST Segment Elevation Myocardial Infarction

Asad Ali  Khan; Rahmat  Ghaffar

doi:10.54112/bcsrj.v6i6.1810

Authors

Asad Ali Khan Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
Rahmat Ghaffar Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i6.1810

Keywords:

Artioventricular block, Acute ST-elevation myocardial infarction (STEMI), Myocardial infarction (MI), Cardiac disease

Abstract

Atrioventricular (AV) block is a recognized complication of acute ST-segment elevation myocardial infarction (STEMI), associated with adverse clinical outcomes. The timely identification of conduction abnormalities can assist in risk stratification and management of affected patients.. Objective: To determine the frequency of atrioventricular block in patients with acute ST-segment elevation myocardial infarction. Methodology: We conducted this cross-sectional study on 104 patients aged 35 to 75 years of either gender presenting with acute STEMI (based on symptoms and ECG criteria). We determined the frequency of atrioventricular block in these patients. AV block was diagnosed through ECG (PR interval >0.20 seconds). Results: Mean age was 57.34±10.86 years. Fifty-eight (55.8%) were male and 46 (44.2%) were female. Nineteen (18.3%) patients had diabetes. Twenty-five (24.0%) had hypertension. Smoking was reported in 16 (15.4%) patients. The frequency of atrioventricular block in our study was 7 (6.7%). Conclusion: The frequency of atrioventricular block in patients with acute ST-segment elevation myocardial infarction in our study was 7 (6.7%).

Downloads

Download data is not yet available.

References

Gue YX, Kanji R, Gati S, Gorog DA. MI with non-obstructive coronary artery presenting with STEMI: a review of incidence, aetiology, assessment and treatment. European Cardiology Review. 2020;15:e20.

Gue YX, Corballis N, Ryding A, Kaski JC, Gorog DA. MINOCA presenting with STEMI: incidence, aetiology and outcome in a contemporaneous cohort. Journal of thrombosis and thrombolysis. 2019;48:533-8.

Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low-and middle-income countries. Current problems in cardiology. 2010;35(2):72-115.

Gehani AA, Al-Hinai AT, Zubaid M, Almahmeed W, Hasani MM, Yusufali AH, et al. Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study. European journal of preventive cardiology. 2014;21(4):400-10.

Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet. 2004;364(9438):937-52.

Wilson PW. Established risk factors and coronary artery disease: the Framingham Study. American journal of hypertension. 1994;7(7_Pt_2):7S-12S.

Canto JG, Kiefe CI, Rogers WJ, Peterson ED, Frederick PD, French WJ, et al. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. Jama. 2011;306(19):2120-7.

Bhatt DL, Lopes RD, Harrington RA. Diagnosis and treatment of acute coronary syndromes: a review. Jama. 2022;327(7):662-75.

Żuchowski B, Błaszyk K, Piskorski J, Wykrętowicz A, Guzik P. Dependence of the Atrioventricular Conduction Time on the Conduction through the Atrioventricular Node and His–Purkinje System. Journal of Clinical Medicine. 2023;12(4):1330.

Wu J, Zipes DP. Mechanisms underlying atrioventricular nodal conduction and the reentrant circuit of atrioventricular nodal reentrant tachycardia using optical mapping. Journal of cardiovascular electrophysiology. 2002;13(8).

Prystowsky E, Jackman W, Rinkenberger R, Heger J, Zipes D. Effect of autonomic blockade on ventricular refractoriness and atrioventricular nodal conduction in humans. Evidence supporting a direct cholinergic action on ventricular muscle refractoriness. Circulation research. 1981;49(2):511-8.

Epstein AE, DiMarco JP, Ellenbogen KA, Estes NM, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Journal of the American College of Cardiology. 2008;51(21):e1-e62.

Hashmi KA, Shehzad A, Hashmi AA, Khan A. Atrioventricular block after acute myocardial infarction and its association with other clinical parameters in Pakistani patients: an institutional perspective. BMC Research Notes. 2018;11:1-4.

Rafla S, Ayad SW, Sanhoury M. Study of bradyarrhythmias in acute myocardial infarction. Egyptian Journal of Critical Care Medicine. 2022;9(2):51-6.

Antoun I, Alkhayer A, Eldin AJ, Alkhayer A, Yazji K, Somani R, et al. The Prevalence and Predictors of Atrioventricular Blocks in Syrian Patients Reporting to the Emergency Department During the Ongoing Conflict: A Cross‐Sectional Study. Journal of Cardiovascular Electrophysiology. 2025.

Dar U, Adnan F, Azizullah NM, Nayyer U. Atrioventricular blocks in patients of acute ST elevation myocardial infarction. PJMHS. 2015;9(3):823-5.

Khan MA, Sammar K, Naz R, Tauqeer S, Shafiq M, Naz S. FREQUENCY OF COMPLETE HEART BLOCK IN PATIENTS PRESENTING WITH ACUTE ANTERIOR WALL MYOCARDIAL INFARCTION. Journal of Ayub Medical College Abbottabad. 2024;36(2):310-5.

Talpur MFH, Shaikh NA, Shah SA, Hulio AA, Detho AS, Faizan M, et al. Frequency of Complete Heart Block (CHB) and Its Association with Hypertension and Diabetes Mellitus in Patients with Anterior Wall Myocardial Infarction (AWMI). Journal of Pharmaceutical Research International. 2022;34(34B):24-9.

Ishida M, Sakai C, Kobayashi Y, Ishida T. Cigarette smoking and atherosclerotic cardiovascular disease. Journal of atherosclerosis and thrombosis. 2024;31(3):189-200.